Prothena Corp Plc (PRTA) - Financial Analysis Review - GlobalData - Company Reports

Prothena Corp Plc (PRTA) - Financial Analysis Review

Prothena Corp Plc (PRTA) - Financial Analysis Review - GlobalData - Company Reports
Prothena Corp Plc (PRTA) - Financial Analysis Review
Published Nov 29, 2016
43 pages — Published Nov 29, 2016
Price US$ 125.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Prothena Corp Plc (Prothena) is a late stage clinical biotechnology company that discovers, develops and markets novel antibodies that are indicated for the treatment of diseases associated with amyloid or cell adhesion. The company concentrates on monoclonal antibodies directed specifically at disease-causing proteins. Its pipeline products comprise PRX002, indicated for the treatment of Parkinsons disease; NEOD001, indicated for the treatment of primary systemic amyloidosis; PRX003, indicated for the treatment of psoriasis and other inflammatory diseases. The company provides research and development services to other pharmaceutical and biotechnology companies.

GlobalData's Prothena Corp Plc (PRTA) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Prothena Corp Plc Key Recent Developments:

Nov 01,2016: Prothena Reports Third Quarter 2016 Financial Results and Provides R&D Update
Oct 03,2016: Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director
Sep 06,2016: Prothena Announces Appointment of Gene G. Kinney as Chief Operating Officer
Aug 02,2016: Prothena Reports Second Quarter 2016 Financial Results; Provides R&D Update
May 19,2016: Prothena to Present Quality of Life Data on AL Amyloidosis at European Hematology Association 21st Congress


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns

  
Source:
Document ID
GDPH459401FA
Industry
Ticker
PRTA=IE
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Section 1 - About the Company41
Prothena Corp Plc - Key Facts51
Prothena Corp Plc - Key Employees61
Prothena Corp Plc - Major Products and Services71
Prothena Corp Plc - Pharmaceutical Pipeline Products Data83
  Prothena Corp Plc, Pipeline Products by Therapy Area81
  Prothena Corp Plc, Pipeline Products by Development Phase92
Prothena Corp Plc - History111
Prothena Corp Plc - Locations And Subsidiaries121
  Head Office121
  Other Locations &Subsidiaries121
Section 2 Company Analysis131
Company Overview131
Prothena Corp Plc - Key Competitors141
Section 3 Company Financial Ratios151
Financial Ratios - Capital Market Ratios151
Financial Ratios - Annual Ratios162
Performance Chart181
Financial Performance181
Financial Ratios - Interim Ratios191
Financial Ratios - Ratio Charts201
Section 4 Company s Lifesciences Financial Deals and Alliances212
  Prothena Corp Plc, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016211
  Prothena Corp Plc, Pharmaceuticals &Healthcare, Deals By Type, 2010 to YTD 2016221
Prothena Corp Plc, Recent Deals Summary231
Section 5 Company s Recent Developments241
Nov 01, 2016: Prothena Reports Third Quarter 2016 Financial Results and Provides R&D Update242
Oct 03, 2016: Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director261
Sep 06, 2016: Prothena Announces Appointment of Gene G. Kinney as Chief Operating Officer271
Aug 02, 2016: Prothena Reports Second Quarter 2016 Financial Results; Provides R&D Update282
May 19, 2016: Prothena to Present Quality of Life Data on AL Amyloidosis at European Hematology Association 21st Congress301
May 03, 2016: Prothena Reports First Quarter 2016 Financial Results and Provides R&D Update312
Feb 24, 2016: Prothena Announces Appointment of Chief Commercial Officer331
Feb 24, 2016: Prothena Announces Appointment of Chief Commercial Officer341
Feb 18, 2016: Prothena Reports Fourth Quarter and Full Year 2015 Financial Results; Provides Financial Guidance and R&D Update352
Nov 02, 2015: Prothena Reports Third Quarter 2015 Financial Results and Provides R&D Update372
Section 6 Appendix395
  Methodology391
  Ratio Definitions394
  About GlobalData431
  Contact Us431
  Disclaimer431

Table Of Contents

GlobalData - Company Reports—GlobalData is an industry analysis specialist, providing business information products and services. These high quality company reports are created via a large research and analysis capability, drawing from extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
GlobalData - Company Reports. "Prothena Corp Plc (PRTA) - Financial Analysis Review" Nov 29, 2016. Alacra Store. Mar 28, 2024. <http://www.alacrastore.com/storecontent/GlobalData-Company-Reports/Prothena-Corp-Plc-PRTA-Financial-Analysis-Review-2087-64462>
  
APA:
GlobalData - Company Reports. (2016). Prothena Corp Plc (PRTA) - Financial Analysis Review Nov 29, 2016. New York, NY: Alacra Store. Retrieved Mar 28, 2024 from <http://www.alacrastore.com/storecontent/GlobalData-Company-Reports/Prothena-Corp-Plc-PRTA-Financial-Analysis-Review-2087-64462>
  
US$ 125.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Company Profiles from one place.